Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder. Academic Article uri icon

Overview

abstract

  • Obsessive-compulsive disorder (OCD) affects approximately one person in 40 and causes substantial suffering. Evidence-based treatments can benefit many; however, optimal treatment can be difficult to access. Diagnosis is frequently delayed, and pharmacological and psychotherapeutic interventions often fail to follow evidence-based guidelines. To ameliorate this distressing situation, the International OCD Accreditation Task Force of the Canadian Institute for Obsessive-Compulsive Disorders has developed knowledge and competency standards for specialized treatments for OCD through the lifespan. These are foundational to evidence-based practice and will form the basis for upcoming ATF development of certification/accreditation programs. Here, we present specialty standards for the pharmacological treatment of adult OCD. We emphasize the importance of integrating pharmacotherapy with clear diagnosis, appreciation of complicating factors, and evidence-based cognitive behavioral therapy. Clear evidence exists to inform first- and second-line pharmacological treatments. In disease refractory to these initial efforts, multiple strategies have been investigated, but the evidence is more equivocal. These standards summarize this limited evidence to give the specialist practitioner a solid basis on which to make difficult decisions in complex cases. It is hoped that further research will lead to development of a clear, multi-step treatment algorithm to support each step in clinical decision-making.

publication date

  • March 4, 2021

Research

keywords

  • Cognitive Behavioral Therapy
  • Obsessive-Compulsive Disorder

Identity

PubMed Central ID

  • PMC8536398

Scopus Document Identifier

  • 85105426343

Digital Object Identifier (DOI)

  • 10.1016/j.psychres.2021.113752

PubMed ID

  • 33975093

Additional Document Info

volume

  • 300